annual CFO:
-$171.17M-$96.41M(-128.96%)Summary
- As of today (June 18, 2025), APGE annual cash flow from operations is -$171.17 million, with the most recent change of -$96.41 million (-128.96%) on December 31, 2024.
- During the last 3 years, APGE annual CFO has fallen by -$154.75 million (-942.03%).
- APGE annual CFO is now -942.03% below its all-time high of -$16.43 million, reached on December 31, 2022.
Performance
APGE Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$48.48M+$19.24M(+28.41%)Summary
- As of today (June 18, 2025), APGE quarterly cash flow from operations is -$48.48 million, with the most recent change of +$19.24 million (+28.41%) on March 31, 2025.
- Over the past year, APGE quarterly CFO has dropped by -$16.84 million (-53.23%).
- APGE quarterly CFO is now -359.19% below its all-time high of -$10.56 million, reached on March 31, 2023.
Performance
APGE quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$188.01M-$16.84M(-9.84%)Summary
- As of today (June 18, 2025), APGE TTM cash flow from operations is -$188.01 million, with the most recent change of -$16.84 million (-9.84%) on March 31, 2025.
- Over the past year, APGE TTM CFO has dropped by -$92.17 million (-96.18%).
- APGE TTM CFO is now -1680.95% below its all-time high of -$10.56 million, reached on March 31, 2023.
Performance
APGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APGE Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -129.0% | -53.2% | -96.2% |
3 y3 years | -942.0% | - | - |
5 y5 years | -942.0% | - | - |
APGE Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -942.0% | at low | -359.2% | +28.4% | -1681.0% | at low |
5 y | 5-year | -942.0% | at low | -359.2% | +28.4% | -1681.0% | at low |
alltime | all time | -942.0% | at low | -359.2% | +28.4% | -1681.0% | at low |
APGE Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$48.48M(-28.4%) | -$188.01M(+9.8%) |
Dec 2024 | -$171.17M(+129.0%) | -$67.71M(+59.2%) | -$171.17M(+28.5%) |
Sep 2024 | - | -$42.52M(+45.1%) | -$133.21M(+20.5%) |
Jun 2024 | - | -$29.30M(-7.4%) | -$110.57M(+15.4%) |
Mar 2024 | - | -$31.64M(+6.3%) | -$95.84M(+28.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$74.76M(+355.1%) | -$29.75M(+49.7%) | -$74.76M(+66.1%) |
Sep 2023 | - | -$19.88M(+36.4%) | -$45.01M(+79.1%) |
Jun 2023 | - | -$14.57M(+38.0%) | -$25.13M(+138.0%) |
Mar 2023 | - | -$10.56M | -$10.56M |
Dec 2022 | -$16.43M | - | - |
FAQ
- What is Apogee Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Apogee Therapeutics?
- What is Apogee Therapeutics annual CFO year-on-year change?
- What is Apogee Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly CFO year-on-year change?
- What is Apogee Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Apogee Therapeutics?
- What is Apogee Therapeutics TTM CFO year-on-year change?
What is Apogee Therapeutics annual cash flow from operations?
The current annual CFO of APGE is -$171.17M
What is the all time high annual CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high annual cash flow from operations is -$16.43M
What is Apogee Therapeutics annual CFO year-on-year change?
Over the past year, APGE annual cash flow from operations has changed by -$96.41M (-128.96%)
What is Apogee Therapeutics quarterly cash flow from operations?
The current quarterly CFO of APGE is -$48.48M
What is the all time high quarterly CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly cash flow from operations is -$10.56M
What is Apogee Therapeutics quarterly CFO year-on-year change?
Over the past year, APGE quarterly cash flow from operations has changed by -$16.84M (-53.23%)
What is Apogee Therapeutics TTM cash flow from operations?
The current TTM CFO of APGE is -$188.01M
What is the all time high TTM CFO for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM cash flow from operations is -$10.56M
What is Apogee Therapeutics TTM CFO year-on-year change?
Over the past year, APGE TTM cash flow from operations has changed by -$92.17M (-96.18%)